<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Ethyl eicosapentaenoic acid</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Ethyl eicosapentaenoic acid</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Ethyl eicosapentaenoic acid</b> (<b>E-EPA</b>, <b>icosapent ethyl</b>) is a medication used to treat hypertriglyceridemia. It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150<span>&nbsp;</span>mg/dL.<span class="mw-ref" id="cite_ref-FDA_PR_2-0"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Ethyl eicosapentaenoic acid</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Ethyl_eicosapentaenoate.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ethyl_eicosapentaenoate.png" data-file-width="1424" data-file-height="1143" data-file-type="bitmap" height="161" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Vascepa</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Eicosapentaenoic acid ethyl ester; Ethyl eicosapentaenoate; Eicosapent; EPA ethyl ester;  E-EPA, Icosapent ethyl (USAN <small><abbr>US</abbr></small>)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/icosapent-ethyl.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/icosapent-ethyl.html'" tppabs="https://www.drugs.com/monograph/icosapent-ethyl.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a613024.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a613024.html'" tppabs="https://medlineplus.gov/druginfo/meds/a613024.html" class="external text external">a613024</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Icosapent_ethyl  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Icosapent_ethyl'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Icosapent_ethyl" class="external text external">Icosapent_ethyl</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Vascepa&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Vascepa&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Vascepa&SearchType=BasicSearch" class="external text external">Vascepa</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Antilipemic Agents</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>none</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">Ethyl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenoate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=86227-47-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=86227-47-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=86227-47-6" class="external text external">86227-47-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/9831415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/9831415'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/9831415" class="external text external">9831415</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem<span> </span><span style="font-weight:normal"><abbr>SID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=7848954  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=7848954'" tppabs="https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=7848954" class="external text external">7848954</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7441'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7441" class="external text external">7441</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB08887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB08887'" tppabs="https://www.drugbank.ca/drugs/DB08887" class="external text external">DB08887</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.8007147.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.8007147.html'" tppabs="http://www.chemspider.com/Chemical-Structure.8007147.html" class="external text external">8007147</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6GC8A4PAYH  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6GC8A4PAYH'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6GC8A4PAYH" class="external text external">6GC8A4PAYH</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D01892  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D01892'" tppabs="https://www.kegg.jp/entry/D01892" class="external text external">D01892</a></span></li><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/C16184  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/C16184'" tppabs="https://www.kegg.jp/entry/C16184" class="external text external">C16184</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:84883  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:84883'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:84883" class="external text external">CHEBI:84883</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL2095209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL2095209'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL2095209" class="external text external">ChEMBL2095209</a></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>22</sub><span>H</span><sub>34</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">330.512</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CCC%3DCCC%3DCCC%3DCCC%3DCCC%3DCCCCC%28%3DO%29OCC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CCC%3DCCC%3DCCC%3DCCC%3DCCC%3DCCCCC%28%3DO%29OCC'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CCC%3DCCC%3DCCC%3DCCC%3DCCC%3DCCCCC%28%3DO%29OCC" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:SSQPWTVBQMWLSZ-AAQCHOMXSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span></td></tr></tbody></table>

<p>It is made from the omega-3 fatty acid <a href="Eicosapentaenoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Eicosapentaenoic_acid" title="Eicosapentaenoic acid">eicosapentaenoic acid</a> (EPA).<span class="mw-ref" id="cite_ref-FDA_PR_2-1"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The US Food and Drug Administration (FDA) granted the approval of it (as Vascepa) in 2012, to Amarin Corporation, and it became the second <a href="Fish_oil.htm" tppabs="https://ptable.com/wiki/compounds/A/Fish_oil" title="Fish oil">fish oil</a>-based medication after omega-3 acid ethyl esters, brand named Lovaza, which was approved in 2004.<span class="mw-ref" id="cite_ref-2015CompareRev_3-0"><a href="#cite_note-2015CompareRev-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> On 13 December 2019, FDA also approved it as the first drug specifically "to reduce cardiovascular risk among patients with elevated triglyceride levels".<span class="mw-ref" id="cite_ref-FDA_PR_2-2"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>The most common side effects are musculoskeletal pain, peripheral edema (swelling of legs and hands), atrial fibrillation, and arthralgia (joint pain).<span class="mw-ref" id="cite_ref-FDA_PR_2-3"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_use">Medical use</h2></summary>
    
<p>E-EPA is used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500<span>&nbsp;</span>mg/dL) hypertriglyceridemia.<span class="mw-ref" id="cite_ref-Label_4-0"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Or it may be used in hypertriglyceridemia ≥ 150<span>&nbsp;</span>mg/dL in those with risk factors for heart disease.<span class="mw-ref" id="cite_ref-FDA_PR_2-4"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Intake of large doses (2.0 to 4.0 g/day) of long-chain omega-3 fatty acids as prescription drugs or dietary supplements are generally required to achieve significant (&gt; 15%) lowering of triglycerides, and at those doses the effects can be significant (from 20% to 35% and even up to 45% in individuals with levels greater that 500<span>&nbsp;</span>mg/dL). It appears that both eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) lower triglycerides, however, DHA alone appears to raise low-density lipoprotein (the variant which drives atherosclerosis; sometimes very inaccurately called: "bad cholesterol") and LDL-C values (always only a calculated estimate; not measured by labs from person's blood sample for technical and cost reasons), whilst EPA alone does not and instead lowers the parameters aforementioned.<span class="mw-ref" id="cite_ref-NLApt2-2015_5-0"><a href="#cite_note-NLApt2-2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other_fish-oil_based_drugs">Other fish-oil based drugs</h3></summary>
    

<p>There are other omega-3 fish-oil based drugs on the market that have similar uses and mechanisms of action:<span class="mw-ref" id="cite_ref-2014rev_6-0"><a href="#cite_note-2014rev-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-2015CompareRev_3-1"><a href="#cite_note-2015CompareRev-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<ul><li>Omega-3 acid ethyl esters (brand names Omarcor, Lovaza, and Omtryg)<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> and, as of March 2016, four generic versions;<span class="mw-ref" id="cite_ref-USgenerics_10-0"><a href="#cite_note-USgenerics-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></li>
<li>Omega-3 carboxylic acids (Epanova);<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> the Epanova brand name was discontinued in the United States.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Dietary_supplements">Dietary supplements</h3></summary>
    
<p>There are many fish oil dietary supplements on the market.<span class="mw-ref" id="cite_ref-2015CompareRev_3-2"><a href="#cite_note-2015CompareRev-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Evidence does not support a beneficial role for n-3 dietary supplements to reduce cardiovascular disease as an addition to contemporary medical therapy including statin therapy.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> The ingredients of dietary supplements are not as carefully controlled as prescription products and have not been fixed and tested in clinical trials, as prescription drugs have,<span class="mw-ref" id="cite_ref-emedDrugs_18-0"><a href="#cite_note-emedDrugs-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> and the prescription forms are more concentrated, requiring fewer capsules to be taken and increasing the likelihood of compliance.<span class="mw-ref" id="cite_ref-2015CompareRev_3-3"><a href="#cite_note-2015CompareRev-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Special caution should be taken with people who have fish and shellfish allergies.<span class="mw-ref" id="cite_ref-Label_4-1"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In addition, as with other omega-3 fatty acids, taking E-EPA puts people who are on anticoagulants at risk for prolonged bleeding time.<span class="mw-ref" id="cite_ref-Label_4-2"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-NLApt2-2015_5-1"><a href="#cite_note-NLApt2-2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>
The most commonly reported side effect in clinical trials has been joint pain; some people also reported pain in their mouth or throat.<span class="mw-ref" id="cite_ref-Label_4-3"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> E-EPA has not been tested in pregnant women and is rated pregnancy category C;<span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> it is excreted in breast milk and the effects on infants are not known.<span class="mw-ref" id="cite_ref-Label_4-4"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>After ingestion, E-EPA is metabolized to EPA. EPA is absorbed in the small intestine and enters circulation. Peak plasma concentration occurs about 5 hours after ingestion and the half-life is about 89 hours. EPA is metabolized mostly in the liver like other dietary fatty acids.<span class="mw-ref" id="cite_ref-Label_4-5"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>EPA, the active metabolite of E-EPA, like other omega-3 fatty acid based drugs, appears to reduce production of triglycerides in the liver, and to enhance clearance of triglycerides from circulating very low-density lipoprotein (VLDL) particles; the way it does that is not clear, but potential mechanisms include increased breakdown of fatty acids; inhibition of diglyceride acyltransferase which is involved in biosynthesis of triglycerides in the liver; and increased activity of lipoprotein lipase in blood.<span class="mw-ref" id="cite_ref-Label_4-6"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-2014rev_6-1"><a href="#cite_note-2014rev-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>E-EPA is an ethyl ester of <a href="Eicosapentaenoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Eicosapentaenoic_acid" title="Eicosapentaenoic acid">eicosapentaenoic acid</a>, which is an omega-3 fatty acid.<span class="mw-ref" id="cite_ref-Label_4-7"><a href="#cite_note-Label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>In July 2012, the US Food and Drug Administration (FDA) approved E-EPA for severe hypertriglyceridemia as an adjunct to dietary measures;<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Amarin Corporation had developed the drug.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Amarin Corporation, challenged the FDA's authority to limit its ability to market the drug for off-label use and won its case on appeal in 2012, changing the way the FDA regulates the marketing of medication.</p>

<p>E-EPA was the second fish-oil drug to be approved, after omega-3 acid ethyl esters (GlaxoSmithKline's Lovaza which was approved in 2004<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-2015CompareRev_3-4"><a href="#cite_note-2015CompareRev-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-PBM2005_22-0"><a href="#cite_note-PBM2005-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span>) and sales were not as robust as Amarin had hoped. The labels for the two drugs were similar, but doctors prescribed Lovaza for people who had triglycerides lower than 500<span>&nbsp;</span>mg/dL based on some clinical evidence. Amarin wanted to actively market E-EPA for that population as well which would have greatly expanded its revenue, and applied to the FDA for permission to do so in 2013, which the FDA denied.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> In response, in May 2015 Amarin sued the FDA for infringing its First Amendment rights,<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> and in August 2015, a judge ruled that the FDA could not "prohibit the truthful promotion of a drug for unapproved uses because doing so would violate the protection of free speech."<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> The ruling left open the question of what the FDA would allow Amarin to say about E-EPA, and in March 2016 the FDA and Amarin agreed that Amarin would submit specific marketing material to the FDA for the FDA to review, and if the parties disagreed on whether the material was truthful, they would seek a judge to mediate.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<p>In December 2019, the FDA approved the use of icosapent ethyl as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat in the blood) of 150 milligrams per deciliter or higher.<span class="mw-ref" id="cite_ref-FDA_PR_2-5"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Patients must also have either established cardiovascular disease or diabetes and two or more additional risk factors for cardiovascular disease.<span class="mw-ref" id="cite_ref-FDA_PR_2-6"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Icosapent ethyl is the first FDA approved drug to reduce cardiovascular risk among patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy.<span class="mw-ref" id="cite_ref-FDA_PR_2-7"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>The efficacy and safety of icosapent ethyl were established in a study with 8,179 patients who were either 45 years and older with a documented history of coronary artery, cerebrovascular, carotid artery and peripheral artery disease, or 50 years and older with diabetes and additional risk factors for cardiovascular disease.<span class="mw-ref" id="cite_ref-FDA_PR_2-8"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Patients who received icosapent ethyl were significantly less likely to experience a cardiovascular event, such as a stroke or heart attack.<span class="mw-ref" id="cite_ref-FDA_PR_2-9"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>In clinical trials, icosapent ethyl was associated with an increased risk of atrial fibrillation or atrial flutter (irregular heart rhythms) requiring hospitalization.<span class="mw-ref" id="cite_ref-FDA_PR_2-10"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The incidence of atrial fibrillation was greater among patients with a history of atrial fibrillation or atrial flutter.<span class="mw-ref" id="cite_ref-FDA_PR_2-11"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Icosapent ethyl was also associated with an increased risk of bleeding events.<span class="mw-ref" id="cite_ref-FDA_PR_2-12"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The incidence of bleeding was higher among patients who were also taking other medications that increase the risk of bleeding, such as aspirin, clopidogrel or warfarin at the same time.<span class="mw-ref" id="cite_ref-FDA_PR_2-13"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/icosapent.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/icosapent.html'" tppabs="https://www.drugs.com/pregnancy/icosapent.html" class="external text external">"Icosapent (Vascepa) Use During Pregnancy"</a>. <i>Drugs.com</i>. 18 February 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-FDA_PR-2"> <span id="mw-reference-text-cite_note-FDA_PR-2" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups'" tppabs="https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups" class="external text external">"FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups"</a>. <i>U.S. Food and Drug Administration (FDA)</i> (Press release). 13 December 2019. <a href="javascript:if(confirm('https://web.archive.org/web/20191222104006/https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20191222104006/https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups'" tppabs="https://web.archive.org/web/20191222104006/https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups" class="external text external">Archived</a> from the original on 22 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2019</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li><li id="cite_note-2015CompareRev-3"> <span id="mw-reference-text-cite_note-2015CompareRev-3" class="mw-reference-text"><cite id="CITEREFIto2015" class="citation journal cs1">Ito MK (December 2015). <a href="javascript:if(confirm('http://www.ptcommunity.com/journal/article/full/2015/12/826/comparative-overview-prescription-omega-3-fatty-acid-products  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ptcommunity.com/journal/article/full/2015/12/826/comparative-overview-prescription-omega-3-fatty-acid-products'" tppabs="http://www.ptcommunity.com/journal/article/full/2015/12/826/comparative-overview-prescription-omega-3-fatty-acid-products" class="external text external">"A Comparative Overview of Prescription Omega-3 Fatty Acid Products"</a>. <i>P T</i>. <b>40</b> (12): 826–57. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468" class="external text external">4671468</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26681905  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26681905'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26681905" class="external text external">26681905</a>.</cite></span></li><li id="cite_note-Label-4"> <span id="mw-reference-text-cite_note-Label-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c1a2828-1583-4414-ab22-a60480e8e508  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c1a2828-1583-4414-ab22-a60480e8e508'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c1a2828-1583-4414-ab22-a60480e8e508" class="external text external">"Vascepa- icosapent ethyl capsule"</a>. <i>DailyMed</i>. 23 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-NLApt2-2015-5"> <span id="mw-reference-text-cite_note-NLApt2-2015-5" class="mw-reference-text"><cite id="CITEREFJacobsonMakiOrringerJones2015" class="citation journal cs1">Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G,  et al. (2015). <a href="javascript:if(confirm('https://doi.org/10.1016/j.jacl.2015.09.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.jacl.2015.09.002'" tppabs="https://doi.org/10.1016/j.jacl.2015.09.002" class="external text external">"National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2"</a>. <i>Journal of Clinical Lipidology</i>. <b>9</b> (6 Suppl): S1–122.e1. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jacl.2015.09.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jacl.2015.09.002'" tppabs="https://doi.org/10.1016%2Fj.jacl.2015.09.002" class="external text external">10.1016/j.jacl.2015.09.002</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26699442  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26699442'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26699442" class="external text external">26699442</a>.</cite></span></li><li id="cite_note-2014rev-6"> <span id="mw-reference-text-cite_note-2014rev-6" class="mw-reference-text"><cite id="CITEREFWeintraub2014" class="citation journal cs1">Weintraub HS (November 2014). "Overview of prescription omega-3 fatty acid products for hypertriglyceridemia". <i>Postgraduate Medicine</i>. <b>126</b> (7): 7–18. doi:<a href="javascript:if(confirm('https://doi.org/10.3810%2Fpgm.2014.11.2828  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3810%2Fpgm.2014.11.2828'" tppabs="https://doi.org/10.3810%2Fpgm.2014.11.2828" class="external text external">10.3810/pgm.2014.11.2828</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25387209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25387209'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25387209" class="external text external">25387209</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFBrintonMason2017" class="citation journal cs1">Brinton EA, Mason RP (January 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870" class="external text external">"Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)"</a>. <i>Lipids Health Dis</i>. <b>16</b> (1): 23. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1186%2Fs12944-017-0415-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fs12944-017-0415-8'" tppabs="https://doi.org/10.1186%2Fs12944-017-0415-8" class="external text external">10.1186/s12944-017-0415-8</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282870" class="external text external">5282870</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28137294  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28137294'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28137294" class="external text external">28137294</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160303225225/http://pharmacyservices.utah.edu/alerts/251.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160303225225/http://pharmacyservices.utah.edu/alerts/251.html'" tppabs="https://web.archive.org/web/20160303225225/http://pharmacyservices.utah.edu/alerts/251.html" class="external text external">"University of Utah Pharmacy Services (15 August 2007) "Omega-3-acid Ethyl Esters Brand Name Changed from Omacor to Lovaza<span class="cs1-kern-right">"</span>"</a>. Archived from <a href="javascript:if(confirm('http://pharmacyservices.utah.edu/alerts/251.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://pharmacyservices.utah.edu/alerts/251.html'" tppabs="http://pharmacyservices.utah.edu/alerts/251.html" class="external text external">the original</a> on 3 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2016</span>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d" class="external text external">"Omtryg- omega-3-acid ethyl esters capsule"</a>. <i>DailyMed</i>. 31 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-USgenerics-10"> <span id="mw-reference-text-cite_note-USgenerics-10" class="mw-reference-text"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=OMEGA-3-ACID%20ETHYL%20ESTERS  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=OMEGA-3-ACID%20ETHYL%20ESTERS'" tppabs="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=OMEGA-3-ACID%20ETHYL%20ESTERS" class="external text external">FDA Omega-3 acid ethyl esters products</a> Page accessed 31 March 2016 </span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=OMEGA-3-ACID+ETHYL+ESTERS  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=OMEGA-3-ACID+ETHYL+ESTERS'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=OMEGA-3-ACID+ETHYL+ESTERS" class="external text external">"Omega-3-acid ethyl esters"</a>. <i>DailyMed</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2020</span>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1324/epanova-omega-3-carboxylic-acids  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1324/epanova-omega-3-carboxylic-acids'" tppabs="http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1324/epanova-omega-3-carboxylic-acids" class="external text external">"Epanova (omega-3-carboxylic acids)"</a>. <i>CenterWatch</i><span class="reference-accessdate">. Retrieved <span class="nowrap">15 December</span> 2014</span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205060Orig1EpanovaTOC.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205060Orig1EpanovaTOC.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205060Orig1EpanovaTOC.cfm" class="external text external">"Drug Approval Package: Epanova (Omega-3-carboxylic acids)"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 28 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/history/epanova.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/history/epanova.html'" tppabs="https://www.drugs.com/history/epanova.html" class="external text external">"Epanova (omega-3-carboxylic acids) FDA Approval History"</a>. <i>Drugs.com</i>. 5 May 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFAmerican_Diabetes_Association2019" class="citation journal cs1">American Diabetes Association (20 December 2019). <a href="javascript:if(confirm('https://care.diabetesjournals.org/content/43/Supplement_1/S48  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://care.diabetesjournals.org/content/43/Supplement_1/S48'" tppabs="https://care.diabetesjournals.org/content/43/Supplement_1/S48" class="external text external">"Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2020"</a>. <i>Diabetes Care</i>. American Diabetes Association. <b>43</b> (Supplement 1): S53. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2337%2Fdc20-S005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2337%2Fdc20-S005'" tppabs="https://doi.org/10.2337%2Fdc20-S005" class="external text external">10.2337/dc20-S005</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1935-5548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1935-5548'" tppabs="https://www.worldcat.org/issn/1935-5548" class="external text external">1935-5548</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31862748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31862748'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31862748" class="external text external">31862748</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFJellingerHandelsmanRosenblitBloomgarden2019" class="citation journal cs1">Jellinger, Paul S.; Handelsman, Yehuda; Rosenblit, Paul D.; Bloomgarden, Zachary T.; Fonseca, Vivian A.; Garber, Alan J.; Grunberger, George; Guerin, Chris K.; Bell, David S. H.; Mechanick, Jeffrey I.; Pessah-Pollack, Rachel; Wyne, Kathleen; Smith, Donald; Brinton, Eliot A.; Fazio, Sergio; Davidson, Michael (13 June 2019). <a href="javascript:if(confirm('https://journals.aace.com/doi/pdf/10.4158/EP171764.APPGL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://journals.aace.com/doi/pdf/10.4158/EP171764.APPGL'" tppabs="https://journals.aace.com/doi/pdf/10.4158/EP171764.APPGL" class="external text external">"AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE"</a>. <i>Endocrine Practice</i>. AACECOR. <b>23</b> (Supplement 2): 14. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4158%2FEP171764.APPGL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4158%2FEP171764.APPGL'" tppabs="https://doi.org/10.4158%2FEP171764.APPGL" class="external text external">10.4158/EP171764.APPGL</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1934-2403  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1934-2403'" tppabs="https://www.worldcat.org/issn/1934-2403" class="external text external">1934-2403</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28437620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28437620'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28437620" class="external text external">28437620</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFSkulas-RayWilsonHarrisBrinton2019" class="citation journal cs1">Skulas-Ray, Ann C.; Wilson, Peter W.F.; Harris, William S.; Brinton, Eliot A.; Kris-Etherton, Penny M.; Richter, Chesney K.; Jacobson, Terry A.; Engler, Mary B.; Miller, Michael; Robinson, Jennifer G.; Blum, Conrad B.; Rodriguez-Leyva, Delfin; de Ferranti, Sarah D.; Welty, Francine K. (17 September 2019). <a href="javascript:if(confirm('https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000000709  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000000709'" tppabs="https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000000709" class="external text external">"Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association"</a>. <i>Circulation</i>. Lippincott Williams &amp; Wilkins. <b>140</b> (12): e687. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2FCIR.0000000000000709  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FCIR.0000000000000709'" tppabs="https://doi.org/10.1161%2FCIR.0000000000000709" class="external text external">10.1161/CIR.0000000000000709</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1524-4539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1524-4539'" tppabs="https://www.worldcat.org/issn/1524-4539" class="external text external">1524-4539</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31422671  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31422671'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31422671" class="external text external">31422671</a>.</cite></span></li><li id="cite_note-emedDrugs-18"> <span id="mw-reference-text-cite_note-emedDrugs-18" class="mw-reference-text"><cite id="CITEREFSweeney2015" class="citation web cs1">Sweeney ME (14 April 2015).  Khardori R (ed.). <a href="javascript:if(confirm('http://emedicine.medscape.com/article/126568-treatment  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emedicine.medscape.com/article/126568-treatment#d8'" tppabs="http://emedicine.medscape.com/article/126568-treatment#d8" class="external text external">"Hypertriglyceridemia Pharmacologic Therapy"</a>. <i>Medscape Drugs &amp; Diseases</i><span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2016</span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057_vascepa_toc.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057_vascepa_toc.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057_vascepa_toc.cfm" class="external text external">"Drug Approval Package: Vascepa (icosapent ethyl) NDA #202057"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 6 March 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text">CenterWatch <a href="javascript:if(confirm('http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1215/vascepa-icosapent-ethyl  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1215/vascepa-icosapent-ethyl'" tppabs="http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1215/vascepa-icosapent-ethyl" class="external text external">Vascepa (icosapent ethyl)</a> Page accessed 31 March 2016</span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm" class="external text external">"Drug Approval Package: Omacor (Omega-3-Acid Ethyl Esters) NDA #021654"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 24 December 1999<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2020</span>.</cite></span></li><li id="cite_note-PBM2005-22"> <span id="mw-reference-text-cite_note-PBM2005-22" class="mw-reference-text">VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel. October 2005 <a href="javascript:if(confirm('http://www.pbm.va.gov/clinicalguidance/drugmonographs/Omega3acidethylestersLovazaformerlyOmacor.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pbm.va.gov/clinicalguidance/drugmonographs/Omega3acidethylestersLovazaformerlyOmacor.pdf'" tppabs="http://www.pbm.va.gov/clinicalguidance/drugmonographs/Omega3acidethylestersLovazaformerlyOmacor.pdf" class="external text external">National PBM Drug Monograph Omega-3-acid ethyl esters (Lovaza, formerly Omacor)</a></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFHerper2013" class="citation web cs1">Herper M (17 October 2013). <a href="javascript:if(confirm('https://www.forbes.com/sites/matthewherper/2013/10/17/why-the-fda-is-right-to-block-amarins-push-to-market-fish-oil-to-millions  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.forbes.com/sites/matthewherper/2013/10/17/why-the-fda-is-right-to-block-amarins-push-to-market-fish-oil-to-millions'" tppabs="https://www.forbes.com/sites/matthewherper/2013/10/17/why-the-fda-is-right-to-block-amarins-push-to-market-fish-oil-to-millions" class="external text external">"Why The FDA Is Right To Block Amarin's Push To Market Fish Oil To Millions"</a>. <i>Forbes</i>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFThomas2015" class="citation news cs1">Thomas K (7 May 2015). <a href="javascript:if(confirm('https://www.nytimes.com/2015/05/08/business/drugmaker-sues-fda-over-right-to-discuss-off-label-uses.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2015/05/08/business/drugmaker-sues-fda-over-right-to-discuss-off-label-uses.html'" tppabs="https://www.nytimes.com/2015/05/08/business/drugmaker-sues-fda-over-right-to-discuss-off-label-uses.html" class="external text external">"Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2017</span>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFPollack2015" class="citation news cs1">Pollack A (7 August 2015). <a href="javascript:if(confirm('https://www.nytimes.com/2015/08/08/business/court-forbids-fda-from-blocking-truthful-promotion-of-drug.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2015/08/08/business/court-forbids-fda-from-blocking-truthful-promotion-of-drug.html'" tppabs="https://www.nytimes.com/2015/08/08/business/court-forbids-fda-from-blocking-truthful-promotion-of-drug.html" class="external text external">"Court Forbids F.D.A. From Blocking Truthful Promotion of Drug"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2019</span>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFThomas2016" class="citation news cs1">Thomas K (9 March 2016). <a href="javascript:if(confirm('https://www.nytimes.com/2016/03/09/business/fda-deal-allows-amarin-to-promote-drug-for-off-label-use.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2016/03/09/business/fda-deal-allows-amarin-to-promote-drug-for-off-label-use.html'" tppabs="https://www.nytimes.com/2016/03/09/business/fda-deal-allows-amarin-to-promote-drug-for-off-label-use.html" class="external text external">"F.D.A. Deal Allows Amarin to Promote Drug for Off-Label Use"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2019</span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/icosapent%20ethyl  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/icosapent%20ethyl'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/icosapent%20ethyl" class="external text external">"Icosapent ethyl"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>



<meta property="mw:PageProp/categorydefaultsort" content="Ethyl Eicosapentaenoic Acid">






<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>